Rheumatoid arthritis

Tapering DMARDs in stable patients is feasible – but is it practical?

Reducing DMARDs in patients in stable remission is feasible with close monitoring, a trial shows, but an Australian expert says several questions need to be addressed before tapering or dose-reduction strategies become routine in clinical practice. The Rheumatoid Arthritis in Ongoing Remission (RETRO) study assessed the effect of tapering and stopping treatment with DMARDs in ...

Already a member?

Login to keep reading.

© 2021 the limbic